Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB)
- PMID: 28336312
- DOI: 10.1016/j.ijantimicag.2017.02.008
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB)
Abstract
Recently, multidrug-resistant tuberculosis (MDR-TB) has become a therapeutic challenge. In addition to drug resistance, drug adverse events, intravenous delivery, cost and availability of some antibiotics in low-income countries have led to a look back to old drugs, especially those efficient against closely related organisms such as Mycobacterium leprae. Here we review the available drugs that respect the conditions above and could be upgraded to first-line therapy for treating MDR-TB and extensively drug-resistant tuberculosis (XDR-TB).
Keywords: Antibiotics; Extensively drug-resistant tuberculosis; MDR-TB; Multidrug-resistant tuberculosis; XDR-TB.
Copyright © 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
Similar articles
-
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43. MMWR Recomm Rep. 2009. PMID: 19214162
-
Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005. Clin Infect Dis. 2008. PMID: 18611154
-
Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.Western Pac Surveill Response J. 2016 Jun 8;7(2):35-40. doi: 10.5365/WPSAR.2016.7.2.002. eCollection 2016 Apr-Jun. Western Pac Surveill Response J. 2016. PMID: 27508089 Free PMC article.
-
Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance.Tuberculosis (Edinb). 2018 Mar;109:17-27. doi: 10.1016/j.tube.2017.12.002. Epub 2017 Dec 9. Tuberculosis (Edinb). 2018. PMID: 29559117 Review.
-
Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.Int J Infect Dis. 2023 Jul;132:50-63. doi: 10.1016/j.ijid.2023.04.392. Epub 2023 Apr 16. Int J Infect Dis. 2023. PMID: 37072053 Free PMC article.
Cited by
-
A highly effective and inexpensive standardized treatment of multidrug-resistant tuberculosis: a multicenter prospective study in China.BMC Infect Dis. 2021 Aug 19;21(1):834. doi: 10.1186/s12879-021-06553-2. BMC Infect Dis. 2021. PMID: 34412615 Free PMC article. Clinical Trial.
-
Biochemical Investigation of Rv3404c from Mycobacterium tuberculosis.Biochemistry. 2017 Jul 25;56(29):3818-3825. doi: 10.1021/acs.biochem.7b00506. Epub 2017 Jul 14. Biochemistry. 2017. PMID: 28665588 Free PMC article.
-
Trends and Progress on Antibiotic-Resistant Mycobacterium tuberculosis and Genes in relation to Human Immunodeficiency Virus.Can J Infect Dis Med Microbiol. 2023 Nov 30;2023:6659212. doi: 10.1155/2023/6659212. eCollection 2023. Can J Infect Dis Med Microbiol. 2023. PMID: 38077655 Free PMC article. Review.
-
Identification of Mutations Associated With Macozinone-Resistant in Mycobacterium Tuberculosis.Curr Microbiol. 2022 May 26;79(7):205. doi: 10.1007/s00284-022-02881-x. Curr Microbiol. 2022. PMID: 35616769
-
Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria.Antimicrob Agents Chemother. 2017 Aug 24;61(9):e01233-17. doi: 10.1128/AAC.01233-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28652235 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
